Amplification of AML1 gene is present in childhood acute lymphoblastic leukemia but not in adult, and is not associated with AML1 gene mutation

被引:35
作者
Penther, D
Preudhomme, C
Talmant, P
Roumier, C
Godon, A
Méchinaud, F
Milpied, N
Bataille, R
Avet-Loiseau, H
机构
[1] Univ Hosp, Lab Hematol, Nantes, France
[2] Univ Hosp, Lab Hematol A, Lille, France
[3] Univ Hosp, Dept Clin Hematol, Nantes, France
关键词
AML1; gene; childhood acute lymphoblastic leukemia; amplification; mutation;
D O I
10.1038/sj.leu.2402479
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The AML1/CBFA2/RUNX1 gene is the target of many recurrent translocations seen in different leukemia subtypes. The t(12;21)(p13;q22) is the most frequent translocation observed in childhood B acute lymphoblastic leukemia (ALL), occurring in 20% to 25% of cases. In adult ALL this rearrangement is scarce. Another route of AML1 deregulation could be point mutations in the runt domain. We now report on AML1 amplification in two cases of childhood ALL, found in a series of 107 consecutive children with B-lineage ALL analyzed by fluorescence in situ hybridization (FISH). A parallel analysis of 42 adult B-ALL failed to detect any AML1 rearrangement by FISH. The two patients with AML1 amplification were further analyzed using molecular techniques. SSCP analysis did not detect any mutation. Furthermore, direct sequencing of the cDNA did not reveal any mutation. In conclusion, AML1 amplification seems to be observed only in childhood ALL and is not associated with AML1 gene mutation. Other mechanisms, such as gene dosage effects could be hypothesized.
引用
收藏
页码:1131 / 1134
页数:4
相关论文
共 23 条
[11]   Mutations of the AML1 gene in myelodysplastic syndrome and their functional implications in leukemogenesis [J].
Imai, Y ;
Kurokawa, M ;
Izutsu, K ;
Hangaishi, A ;
Takeuchi, K ;
Maki, K ;
Ogawa, S ;
Chiba, S ;
Mitani, K ;
Hirai, H .
BLOOD, 2000, 96 (09) :3154-3160
[12]   Low frequency of TEL/AML1 in adult acute lymphoblastic leukemia [J].
Kwong, YL ;
Wong, KF .
CANCER GENETICS AND CYTOGENETICS, 1997, 98 (02) :137-138
[13]   Incidence of TEL/AML1 fusion in children with relapsed acute lymphoblastic leukemia [J].
Loh, ML ;
Silverman, LB ;
Young, ML ;
Neuberg, D ;
Golub, TR ;
Sallan, SE ;
Gilliland, DG .
BLOOD, 1998, 92 (12) :4792-4797
[14]   Role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation [J].
Lutterbach, B ;
Hiebert, SW .
GENE, 2000, 245 (02) :223-235
[15]   Evaluation of minimal residual disease using reverse-transcription polymerase chain reaction in t(8;21) acute myeloid leukemia:: A multicenter study of 51 patients [J].
Morschhauser, F ;
Cayuela, JM ;
Martini, S ;
Baruchel, A ;
Rousselot, P ;
Socié, G ;
Berthou, P ;
Jouet, JP ;
Straetmans, N ;
Sigaux, F ;
Fenaux, P ;
Preudhomme, C .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (04) :788-794
[16]  
Niini T, 2000, HAEMATOLOGICA, V85, P362
[17]   Hematopoiesis in the fetal liver is impaired by targeted mutagenesis of a gene encoding a non-DNA binding subunit of the transcription factor, polyomavirus enhancer binding protein 2/core binding factor [J].
Niki, M ;
Okada, H ;
Takano, H ;
Kuno, J ;
Tani, K ;
Hibino, H ;
Asano, S ;
Ito, Y ;
Satake, M ;
Noda, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (11) :5697-5702
[18]   Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2αB gene associated with myeloblastic leukemias [J].
Osato, M ;
Asou, N ;
Abdalla, E ;
Hoshino, K ;
Yamasaki, H ;
Okubo, T ;
Suzushima, H ;
Takatsuki, K ;
Kanno, T ;
Shigesada, K ;
Ito, Y .
BLOOD, 1999, 93 (06) :1817-1824
[19]   High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2αB gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21 [J].
Preudhomme, C ;
Warot-Loze, D ;
Roumier, C ;
Grardel-Duflos, N ;
Garand, R ;
Lai, JL ;
Dastugue, N ;
Macintyre, E ;
Denis, C ;
Bauters, F ;
Kerckaert, JP ;
Cosson, A ;
Fenaux, P .
BLOOD, 2000, 96 (08) :2862-2869
[20]  
Raynaud S, 1996, LEUKEMIA, V10, P1529